Reaction
Haemoperitoneum reporting signals
As of the last recalculation, Haemoperitoneum appears in 775 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is APIXABAN (PRR 38.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Apixaban | 85 | 38.2 | 38.2 |
| Epoprostenol | 16 | 33.5 | 33.5 |
| Heparin Sodium | 15 | 29.8 | 29.9 |
| Acetylcysteine | 10 | 28.9 | 28.9 |
| Remdesivir | 14 | 28.7 | 28.7 |
| Amphotericin B | 13 | 28.3 | 28.4 |
| Meropenem | 29 | 25.2 | 25.2 |
| Linezolid | 25 | 23.3 | 23.3 |
| Dalteparin Sodium | 9 | 23.1 | 23.1 |
| Emicizumab | 10 | 22.0 | 22.0 |
| Piperacillin And Tazobactam | 10 | 21.3 | 21.3 |
| Piperacillin Sodium,Tazobactam Sodium | 20 | 20.8 | 20.8 |
| Valganciclovir Hydrochloride Powder, | 9 | 20.0 | 20.1 |
| Amikacin | 12 | 19.2 | 19.2 |
| Tranexamic Acid | 6 | 18.3 | 18.3 |
| Ceftriaxone | 21 | 17.6 | 17.7 |
| Mycophenilic Acid | 13 | 17.1 | 17.1 |
| Romiplostim | 9 | 16.2 | 16.2 |
| Norepinephrine | 6 | 15.2 | 15.2 |
| Encorafenib | 5 | 13.6 | 13.6 |
| Atezolizumab | 19 | 13.4 | 13.5 |
| Eltrombopag Olamine | 10 | 11.8 | 11.8 |
| Alteplase | 6 | 10.8 | 10.8 |
| Levonorgestrel | 65 | 9.4 | 9.4 |
| Etonogestrel | 8 | 4.5 | 4.5 |